13D/13G Filings - Genexine Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-05-03
08:56 am
Unchanged
2022-09-15 13D ANTRIABIO INC
ANTB
Genexine Inc. 1,826,019
4.960%
0
(Unchanged)
Filing
History
2021-07-28
5:15 pm
Purchase
2019-01-30 13D ANTRIABIO INC
ANTB
Genexine Inc. 1,826,019
21.900%
1,826,019increase
(New Position)
Filing
History
2021-06-21
11:10 am
Sale
2021-05-19 13G I-Mab
IMAB
Genexine Inc. 8,488,885
4.970%
-2,083,938decrease
(-19.71%)
Filing
History
2021-02-16
08:01 am
Purchase
2020-12-31 13G I-Mab
IMAB
Genexine Inc. 10,572,823
6.290%
10,572,823increase
(New Position)
Filing
History